Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Roxas Accepts Price Controls in Cheaper Medicines Bill (Phillipines)

This article was originally published in PharmAsia News

Executive Summary

A large obstacle has been removed clearing the path for legislation designed to allow greater access to affordable medications in the Philippines. Previously, Senator Manual Roxas II had been one of the biggest opponents to a provision in the Philippines House version of the bill that would set up market controls to reduce drug prices. Mr. Roxas' now says that price controls could provide needed insurance if market competition from generics and imports is not sufficient to lower drug prices. Roxas' concession could prove a major leg up for the bill if it passes its readings in the House and the Senate and goes to a bicameral conference. (Click here for more - May Require Free Registration

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC065695

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel